Tcg Crossover Management, LLC Portfolio Holdings

Tcg Crossover Management, LLC

  • $415 Million
  • Q1 2025

Tcg Crossover Management, LLC has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $415 Million distributed in 38 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cogent Biosciences, Inc. with a value of $41.7M, Centessa Pharmaceuticals PLC with a value of $41.6M, Ocular Therapeutix, Inc with a value of $39M, Savara Inc with a value of $34.2M, and Compass Pathways PLC with a value of $32.9M.

Examining the 13F form we can see an decrease of $197M in the current position value, from $612M to 415M.

Tcg Crossover Management, LLC is based out at Palo Alto, CA

Below you can find more details about Tcg Crossover Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $415 Million
Healthcare: $415 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$402M
$41.7 Million 10.05% of portfolio
6,964,375
Q2 2024 Added 12.07%
$1.12B
$41.6 Million 10.01% of portfolio
2,890,816
Q2 2024 Added 41.65%
$664M
$39 Million 9.39% of portfolio
5,319,148
Q1 2024 New
$285M
$34.2 Million 8.25% of portfolio
12,362,205
Q2 2024 Added 23.62%
$363M
$32.9 Million 7.94% of portfolio
3,858,000
Q3 2023 New
$737M
$27.7 Million 6.68% of portfolio
2,650,150
Q1 2024 Added 60.6%
$445M
$27 Million 6.49% of portfolio
2,898,103
Q1 2025 Added 45.7%
$570M
$26.1 Million 6.28% of portfolio
2,452,138
Q4 2024 Added 1.03%
$300M
$21 Million 5.07% of portfolio
5,943,812
Q1 2025 Added 27.99%
$290M
$19.4 Million 4.66% of portfolio
3,572,335
Q4 2024 Added 287.31%
$30.2M
$16 Million 3.85% of portfolio
13,090,200
Q1 2025 Reduced 0.34%
$376M
$15.1 Million 3.64% of portfolio
5,250,000
Q3 2024 New
$75.1M
$14.7 Million 3.55% of portfolio
2,761,861
Q2 2024 Reduced 47.68%
$309M
$14.7 Million 3.54% of portfolio
10,736,000
Q4 2024 New
$439M
$9.4 Million 2.26% of portfolio
1,423,642
Q4 2022 Added 5.56%
$210M
$8.69 Million 2.09% of portfolio
2,505,424
Q4 2024 Added 3.74%
$65.5M
$5.62 Million 1.35% of portfolio
2,240,809
Q2 2024 Added 1.8%
$259M
$5.29 Million 1.27% of portfolio
584,955
Q4 2022 Reduced 8.91%
$204M
$3.22 Million 0.78% of portfolio
1,145,538
Q4 2024 Added 13.63%
$126M
$2.72 Million 0.66% of portfolio
4,000,000
Q1 2024 New
$127M
$363,000 0.09% of portfolio
316,195
Q2 2024 Reduced 61.24%
$63.3M
$120,000 0.03% of portfolio
86,795
Q1 2024 Reduced 82.17%
$389M
$0 0.0% of portfolio
0
Q1 2025 Sold Out
Vistagen Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Upstream Bio Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Adverum Biotechnologies Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 10.55%
Tourmaline Bio Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 46.6%
Avalo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Cidara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 50.0%
Cg Oncology Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 2.8%
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Added 53.05%
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 4.46%
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 22.45%
Mbx Biosciences Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Abivax Sa American Depositary Shares
-
$0 0.0% of portfolio
-
Q2 2024 Added 450.6%

Summary

  • Portfolio
  • No. of Stocks 38
  • Current Value $415 Million
  • Prior Value $612 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 14, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 0 stocks
  • Additional Purchases 2 stocks
  • Sold out of 1 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Tcg Crossover Management, LLC Portfolio

Follow Tcg Crossover Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Crossover Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Crossover Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email